Nicholas Corcoran - 23 Feb 2024 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
SVP of Supply Chain and Operations
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
23 Feb 2024
Net transactions value
$0
Form type
4
Filing time
27 Feb 2024, 17:00:37 UTC
Previous filing
22 Feb 2023
Next filing
08 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Award $0 +11,441 +89% $0.000000 24,327 23 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Award $0 +17,632 $0.000000 17,632 23 Feb 2024 Common Stock 17,632 $83.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 11,441 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 23, 2024 until the option is fully vested on February 23, 2028, subject to continued service.

Remarks:

SVP of Supply Chain and Operations